The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients
Abstract Aims Ivabradine has been used in patients who have chronic heart failure (HF) with reduced ejection fraction (HFrEF) and concomitant sinus heart rate ≥70 bpm. This administration for acute HFrEF remains a concern. This study used a real‐world multicentre database to investigate the effects...
Main Authors: | Chia‐Te Liao, Jin‐Long Huang, Huai‐Wen Liang, Fa‐Po Chung, Ying‐Hsiang Lee, Po‐Lin Lin, Wei‐Ru Chiou, Wen‐Yu Lin, Chien‐Yi Hsu, Hung‐Yu Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13536 |
Similar Items
-
Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
by: Ying‐Hsiang Lee, et al.
Published: (2021-04-01) -
Early administration of ivabradine in patients admitted for acute decompensated heart failure
by: Teng-Yao Yang, et al.
Published: (2022-11-01) -
Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF
by: Norman Mangner, et al.
Published: (2023-10-01) -
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
by: Leonie Grossekettler, et al.
Published: (2020-05-01) -
The Predictive Value of Eosinophil Indices for Major Cardiovascular Events in Patients with Acute Decompensated HFrEF
by: Aslı Vural, et al.
Published: (2022-10-01)